OOIR: Observatory of International Research

Papers

(The median citation count of Nephrology Dialysis Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases	199
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients	184
Immunoengineering for autoimmune-kidney disease	136
Anti-C1Q monitoring predicts relapses of lupus nephritis	118
#1237 Management of dyslipidaemia with evolocumab in kidney transplant recipients	110
MO1005: Analysis of Expression of Immune System Genes that are Responsible for Activation and Inhibition of T-Cell Immune Response in Renal Transplant Recipients after Extracorporeal Photochemotherapy	86
MO197: Change in the Level Of NFKBP65 Gene Expression in the Myocardium and Kidneys of Wistar Rats and Spontaneously Hypertensive Rats (SHR) That Received Diet Rich in NACL	84
#3055 Replacement of tunneled cuffed hemodialysis catheters on coated guidewire: a strategic approach to treat CVC-related infections	84
FC077: Cystatin C Testing Improves Risk Stratification Associated with Chronic Kidney Disease Without Adopting Age-Adapted Diagnostic Thresholds: A UK Biobank Study	81
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION	68
FC029: A Multivariate Model Identifies Genotype, Hypertension and Kidney Length as Independent Baseline Predictors of Disease Progression in a Longitudinal Autosomal Dominant Polycystic Kidney Disease	64
MO227: Anca-Associated Vasculitis Following Pfizer-Biontech COVID-19 Vaccine: True Association or Circumstantial?	63
#2387 Case study of a patient with gouty nephropathy treated with immunosorbent therapy	62
#606 Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease	61
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES	61
#802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe	58
#3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective	57
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS	54
#675 Application of ANCA-associated vasculitis Histopathological Classification and Renal Risk Score for prediction of end-stage kidney disease	53
#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS	52
MO916: Anxiety and Depression Among Dialysis Centre Staff and Haemodialysis Patients During the COVID-19 Pandemic	51
MO1029: Is there a Relationship Between Fibroblast Growth Factor 23 and Blood Pressure in Children with Chronic Kidney Disease?	51
#3144 KIDNEY TRANSPLANT-RELATED KNOWLEDGE AMONG SOUTH ASIAN COMPARED TO WHITE CANADIAN PATIENTS	49
#6279 ESKD TREATMENTS: A DIFFICULT CHOICE TO ELDERLY PATIENTS?	48
#2294 Muscle ultrasound as a tool for morphofunctional assessment in patients with chronic kidney disease	48

MO142: Urinary Hemopexin As a Marker of Lupus Activity Among Egyptian SLE Patients with Proliferative Lupus Nephritis	47
#4585 POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER: COMPARISON OF RISK AND PROGNOSTIC FACTORS BETWEEN KIDNEY AND OTHER ORGAN TRANSPLANT RECIPIENTS	47
#1818 Association of combined systemic inflammatory indices with the severity and outcome of tunnelled hemodialysis catheter-related bacteremia	46
#2917 Desensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications	45
#5285 SERUM IRON AND NUTRITIONAL STATUS ARE ASSOCIATED IN PATIENTS WITH CHRONIC KIDNEY DISEASE	45
#2118 Monitoring hemodynamics in dialysis: on the feasibility of semi-continuous and multifrequency thoracic bioimpedance measurements by a wearable device	45
#3140 THE WEST OF SCOTLAND AND THROMBOTIC MICROANGIOPATHY	44
MO048: Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases	43
#1350 Finerenone in real-life clinical practice: first results from a pilot study	43
MO144: Behind the Scenes: A Year in an Onco-Nephrology Outpatient Clinic in Italy	42
#2695 A Polycystin-1-Bicaudal C1 complex regulates focal adhesion function through integrin beta-1, F-actin organisation and local translation in HKE cells	40
#1834 Prevalence of nephrolithiasis in patients with idiopathic hypercalciuria after two decades of follow-up	40
MO1019: Sigma-1 Receptor Agonists are Protective in a Rat Model of Kidney Transplantation	40
#6368 PLATELET TO LYMPHOCYTE RATIO AND SICKLE CELL NEPHROPATHY	40
#6848 DIABETES AND HEMODIALYSIS ARTERIOVENOUS ACCESS CONSTRUCTION – A RETROSPECTIVE STUDY IN A SINGLE CENTER	39
MO273: Water Restriction and Age Increase the Risk of Triple Whammy-Induced Acute Kidney Injury	39
#4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS	39
#5730 PERLECAN AS A POTENTIAL BIOMARKER OF CARDIOVASCULAR RISK: ROLE OF ENDOTHELIAL GLYCOCALYX IN CHRONIC KIDNEY DISEASE	38
MO522: The Effect of Statin on Anemia in Patients With End-Stage Kidney Disease Receiving Hemodialysis: A Systematic Review and Meta-Analysis	38
MO405: Leucine-Rich Alpha-2-Glycoprotein as a Potential Marker of Mesangial Cell Proliferation in Immunoglobulin a Nephropathy	38
#5536 CIRCULATING LEVELS OF COPEPTIN, GROWTH DIFFERENTIATION FACTOR 15 (GDF15) AND INTERLEUKIN 6 (ILA-6) IN PATIENTS WITH ADVANCED KIDNEY DISEASE	38
#761 Effect of ketoanalogue-supplemented very low protein diet in the need to initiate renal replacement in chronic kidney disease patients	37
MO753: Marinobufagenin Predicts Intradialytic Hypotension Episodes in Prevalent Haemodialysis Patients	37
#5349 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY	37
MO675: A New in Vivo Multi-Photon Microscopy Based Approach to Study the Peritoneal Membrane Changes Induced by Peritoneal Dialysis	37
#3296 ADVERSE MUSCLE COMPOSITION ASSESSED BY MRI ASSOCIATES TO POOR FUNCTIONAL PERFORMANCE AND METABOLIC COMORBIDITIES IN CKD	37
#4720 SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN	37
MO766: Sodium Citrate Versus Heparin Locking Solutions for Tunnelled Haemodialysis Catheters: A Retrospective Analysis	36
#5448 INCIDENCE OF ACUTE PULMONARY EDEMA AFTER THE SYSTEMATIC USE OF ULTRASOUND B-LINES	36
#3166 RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSIS	36
#651 Diagnostiс criteria of the functional state of the kidneys in patients with type 2 diabetes mellitus	36
MO826: Long-Term Impact of COVID-19 Pandemic on HD Adequacy and Patient Care in Alexandria, Egypt: A Multi-Centre Study	35
#2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS	34
#3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN	34
#1962 Development of triple-whammy induced pre-renal AKI is highly dependent on the hydration status	34
#2531 AGATSTON INDEX AS A PREDICTOR OF PREDICTION OF THE DEGREE OF HEART VASCULAR DAMAGE IN STAGE 5 CKD PATIENTS RECEIVING PROGRAM HEMODIALYSIS	34
#6005 COMPARISON OF SEMAGLUTIDE ORAL VS SUBCUTANEOUS IN CHRONIC KIDNEY DISEASE (CKD)	33
#1315 Management and long-term outcome of recurrent idiopathic FSGS in pediatric renal transplant recipients	33
#3121 THE EFFECTIVENESS OF A GLUTEN-FREE DIET IN PATIENTS WITH IGA NEPHROPATHY	32
#1795 Diverse histological findings of kidney injury in cancer patients on immunotherapy- impact on clinical management	32
#1076 DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/ P66shc signaling pathway in diabetic kidney disease	32
#2251 Long-term systolic blood pressure variability as an independent risk factor for cardiovascular events in kidney transplant recipients	32
#1846 Oxalate nephropathy in diabetic kidney disease: another factor to take into account?	32
#1716 IgA nephropathy: our center's experience	31
#4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE	31
#5532 COVID-19 INFECTION MODIFIES GLOMERULAR DISEASE EVOLUTION	31
#5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS	31
#2671 Renal tubular epithelial FFAR4 improves cellular senescence to alleviate interstitial fibrosis in CKD	31
#635 Effect of multi-biomarker panels based on urinary N-terminal osteopontin on prediction of diabetic kidney disease in patients with diabetes mellitus	31
MO841: Anxiety and Depression in Maintenance Hemodialysis Patients: Prevalence and Their Effects on Health-Related Quality of Life	30

#2556 Therapeutic monitoring in patients with APRT deficiency using UPLC-MS/MS-based plasma assay	29
#6891 MACHINE LEARNING NEPHROPATHOLOGY DIAGNOSTICS OF THROMBOTIC MICROANGIOPATHIES	29
#821 Kibra mediates the activation of hippo by classic signal pathway related to NPHP1 defect	29
#5785 ACUTE KIDNEY INJURY AS A RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AND MORTALITY IN HOSPITALIZED PATIENTS	29
MO869: SARS-COV-2 Neutralizing Antibodies in Patients on Hemodialysis After Vaccination	29
#972 A Novel Single Compound from Chinese Herbs as a Potential Candidate for Reducing obesity induced diabetic nephropathy via ATF3-RARRES1 axis pathway	29
#2529 The role of the circadian clock system in the transition from acute kidney injury to chronic kidney disease	29
#3641 DOES IBANDRONATE OR CALCIUM AND VITAMIN D MAINTAIN OR IMPROVE BONE MICROARCHITECTURE IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION?	29
#1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project	29
#5958 VALUE OF EXOME SEQUENCING “FIRST” FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	28
#4758 IMPACT OF GENDER ON CHRONIC KIDNEY DISEASE IN ELDERLY	28
#3958 PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY	28
#3812 ARE KIDNEY CYSTS MORE COMMON IN PEOPLE WITH COL4A3/COL4A4 PATHOGENIC VARIANTS?	28
FC033: Genome-Wide Association Meta-Analysis Identifies Novel Loci for Kidney Failure	28
#4554 FRAX® ASSOCIATION, BONE DENSITOMETRY, BIOCHEMICAL PARAMETERS OF BONE MINERAL METABOLISM AND ADVANCED CHRONIC KIDNEY DISEASE	28
#2963 Light chain deposition in the kidney is more frequent in patients with proliferative lupus nephritis	27
#6915 IMMUNOLOGIC EFFECTS OF THE DECREASE OF IMMUNOSUPPRESSION AFTER SARS-COV-2 INFECTION IN KIDNEY TRASPLANT RECIPIENTS	27
#860 The role of immunocorrection in the treatment of patients chronic pyelonephritis	27
#2740 Pregnancy outcomes in patients with IgA nephropathy and the impact of pregnancy on the renal disease	27
#814 Inflammatory biomarkers and progression of diabetic kidney disease	27
#2699 Rare glomerular microangiopathy: clinicopathological characteristics and prognosis	27
#543 Cognitive improvement in end stage renal disease patients post transplantation—a prospective observational study	27
#5142 THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT	26
#2116 Socioeconomic position and incidence of chronic kidney disease in Central Italy	26
#2868 PREDICTION OF MAJOR GASTROINTESTINAL BLEEDING EVENTS IN HEMODIALYSIS	26
#1839 Evaluating the severity of restless legs syndrome in chronic kidney disease patients across different renal replacement therapies	26
MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts	25
#2439 The association between vitamin D deficiency and sarcopenia in patients with pre-dialysis CKD	25
#3261 SAR131675, A SELECTIVE VEGFR3 INHIBITOR, AMELIORATES RENAL INFLAMMATION AND LYMPHANGIOGENESIS IN THE MURINE LUPUS NEPHRITIS MODEL	25
#6456 DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS	25
#1704 GLP-1RA versus DPP-4 inhibitors and rates of hyperkalemia and discontinuation of renin-angiotensin system (RAS) blockade in Swedish routine care	25
MO998: Kidney Donor Risk Index Correlates with the Worse Recipients And Grafts Survival in a Polish Cohort	25
MO688: Peritoneal Protein Clearance, Inflammation, Nutrition and Overhydration in PD Patients: Looking for the Culprit	25
FC089: The Absence of Sting Prevents Peritoneal Damage in a Murine Model of Peritoneal Fibrosis	25
#2685 SLC34A2 EXACERBATES TUBULAR INTERSTITIAL FIBROSIS VIA INDUCTION OF APOPTOSIS AND CELL CYCLE ARREST IN S PHASE	24
#2450 Alternative splicing in podocytes under mechanical stress: a new perspective for the pathogenic effect of glomerular hypertension	24
MO275: A Biomarker of Acute Kidney Injury from Proven Renal Origin	24
#1304 Clinical characteristics of acute kidney injury caused by Phytolaccaceae ingestion	24
#5599 FEBUXOSTAT IN COMBINATION WITH ANAKINRA OR PH NEUTRALIZATION IMPROVE THE OUTCOMES IN HYPERURICEMIA-RELATED URIC ACID CRYSTALLURIA IN MICE	24
#1297 Approaches to renal response assessment in rare monoclonal immunoglobulin related glomerulopathies	24
#1906 Lung ultrasound as a valid tool for fluid assessment in dialysis patients: a systematic review	24
#6442 HOW CAN IT BE NEPHROANGIOSCLEROSIS? HE´S BEING TREATED ONLY WITH ONE ANTIHYPERTENSIVE DRUG	24
#2394 Inhibition of ACSS2-mediated H3K9 crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence	24
#2388 Relevance of anti-PLA2R levels in therapy decision and prediction of therapy outcome in patients with membranous nephropathy	24
#5882 BENEFIT OF LONG-TERM TOLVAPTAN ADMINISTRATION ON KIDNEY DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTRE EXPERIENCE	24
MO081: Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Kidney Transplant Recipients: A Comparative Study Against Chronic Kidney Disease Patients	23
#289 Lipocalin-2 promotes cardiovascular calcification in chronic kidney disease by upregulating STAT3/NCOA4-mediated ferritinophagy and ferroptosis	23
#6896 A SCREENING AND CLINICAL MANIFESTATIONS OF FABRY DISEASE IN PATIENTS ATTENDING DIALYSIS AND NEPHROLOGY CLINICS IN DURBAN, SOUTH AFRICA	23
#5645 SHORT-CHAIN FATTY ACIDS, PROPIONATE AND BUTYRATE, RESEMBLE THE BENEFICIAL EFFECTS OF VITAMIN D DURING ACUTE KIDNEY DAMAGE	23
MO550: Vascular Cells Senescence and Modifications in NRF2 Pathway in a Model of URaEMIC Vascular Calcification	23
#6672 THE DEVELOPMENT OF A COMMUNITY-NEPHROLOGY, MULTI-DISCIPLINARY SERVICE	22
#1683 Gut permeability, circulating bacterial fragments, and left ventricular strain in peritoneal dialysis	22
#1157 Body mass and fluid balance in dialysis: global profiles in Apollo Dial DB	22
#1914 Comprehensive single-cell sequencing and lipidomics identify diverse injury states and cholesterol dynamics of the PTs in AKI-to-CKD transition	22
#6668 PREDICTION OF REMAINING RENAL FUNCTION IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY DUE TO RENAL TUMOUR MASS AND AFTER NEPHRECTOMY IN LIVING DONORS	22
#801 Impact of delayed graft function on cardiovascular events in kidney transplant recipients	22
MO556: Markers of Oxidative Stress and Coronary Calcifications in Chronic Hemodialysis Patients	22
#1916 Infective endocarditis in young female hemodialysis patient: a case report and literature review	22
#2745 New strategies for capturing undiagnosed chronic kidney disease in patients at risk	22
#598 Successful application of allo-hemodialysis in a porcine model of embolization-induced acute kidney injury	21
#1281 Torque teno virus load in kidney transplantation: association with donor and recipient characteristics and clinical follow-up data	21
#672 Intradialytic hypotension and adverse symptoms are not related	21
MO490: Fast and High Phosphate Reduction With Lanthanum Dioxycarbonate Versus Selevamer In In-Vivo Study	21
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis	21
#2550 Micro(nano)plastics in human urine: a surprising contrast between Chongqing's urban and rural regions	21
#2967 C-reactive protein/serum chloride ratio: a novel marker of all-cause mortality in prevalent chronic haemodialysis patients	21
Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire	21
#1063 Impact of geriatric nutritional risk index on renal function in elderly chronic kidney disease patients treated with SGLT2 inhibitors	21
#2588 Renal trajectories in the french RaDiCo Alport syndrome cohort	20
#291 Prevalence and patterns of intradialytic arterial oxygen saturation instability: observations in a large U.S. hemodialysis cohort	20
#2649 Investigation of the Rac1-SGK1 pathway and therapeutic effects of finerenone and Rac1 inhibition in a Fabry disease podocyte model	20
#3257 Urinary metabolomics in nephrotic syndrome: the experience of “Fondazione Policlinico Universitario A. Gemelli”	20
#2398 Exogenous a-Klotho supplementation significantly prolongs survival in a mouse model of alport syndrome, with comparable outcomes to RASi	20
#1881 Evaluating the clinical and economic impact of SGLT-2 inhibitors for CKD management in the UK: insights from the IMPACT CKD microsimulation model	20
#2590 Evolutionary origins of polycystic kidney disease genes: insights from emerging phylogenomic methodologies	20
#2706 Genetically determined reduction of renal carbonic anhydrase 12 is associated with decreased kidney function and increased serum urate	20
#3063 Real-world utility of the International IgA Nephropathy Prediction Tool in a tertiary referral centre of nephrology	19
#3134 Implementation of an iohexol-based GFR-measurement in clinical routine	19
#949 Vitamin K dependent proteins and bone quality in the first year after kidney transplantation	19
#960 A single-centre service evaluation of patient-centred twice-weekly dialysis delivery	19

#2889 Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart	19
#2638 Recombinant zoster vaccine (RZV) confers persistent immune responses with no safety concerns 4 to 8 years after vaccination of adults with renal transplant	19
#1685 Multimodal spatial profiling of microvascular inflammation in kidney allografts	19
#1796 The impact of metabolic syndrome components on renal function in patients with heart failure	18
#1727 Kidney function associated with mortality in hantavirus infection: a cohort study in BRAZIL	18
#3777 Roles of antiHLA antibodies in the onset of MACE in a population of patients on dialysis and on the waiting list for kidney transplant. A retrospective single-center study	18
#1922 Association of parathyroid hormone and alkaline phosphatase with fracture risk in patients with chronic kidney disease not on dialysis	18
#623 SGLT2 inhibitors in adult patients with Alport syndrome: a single center Italian experience	18
#2266 Integrating palliative care into nephrology: a single-center “action-research” process	18
#3268 Cognitive decline in hemodialysis patients : a prospective cross-sectional study analysing sociodemographic and clinical determinants	18
#3385 The short and long-term accuracy of urinary C-C motif Chemokine-14 in an ICU population	18
#2271 SGLT2 inhibition triggers aestivation-like metabolic switches for water conservation in patients with heart failure—results from DAPA-Shuttle1, a randomized, placebo-controlled trial	18
#147 Evidence of impaired myocardial perfusion reserve in asymptomatic non-diabetic patients with advanced CKD	18
#2731 Legacy effect of pretransplant immunosuppression in kidney transplant recipients with crescentic glomerulonephritis	18
#450 Comparison of Thymoglobulin® vs Grafalon® as induction treatment in kidney transplantation with maastricht type III donor	17
#3313 A novel identification of anti-hypertensive drug spironolactone as an inhibitor of paraoxonase 2 lactonase and anti-ROS activities	17
#3480 Dehydration and hypertension differently prime intrinsic and pre-renal AKI	17
#2491 Exploring the association between non-alcoholic fatty liver disease and chronic kidney disease: insights from NHANES 1999–2016	17
#2190 The protective effects of a ketogenic diet in experimental glomerulonephritis are independent of the Hca2 receptor	17
#2661 Interplay between polymorphism in the EDNRA gene and endothelin-1 concentration in the blood of patients with chronic kidney disease	17
#1100 “Unraveling the genetic complexity of autosomal dominant polycystic kidney disease: insights from gene conversion events”	17
#2980 Association between body mass index and nephrolithiasis markers in the Mexican population	17
#3387 Hepatitis, acute kidney injury and myositis due to atorvastatin	17
#3842 Significant association between B lymphocytes and their subpopulations with peripheral T follicular cells is evident in patients with systemic lupus erythematosus (SLE) at remission	17
#3075 Comparison of β-blocker with other anti-hypertensive drugs in patients with chronic kidney disease in Korea: a national health insurance data	17
#1644 Evaluation of clinical consequences in diverse forms of fistula elevation procedure	17
#1519 Granulomatous interstitial nephritis in a patient with metastatic melanoma on target therapy with dabrafenib and trametinib: a case report	17
#1793 Renal protective effect of SGLT2 inhibitors in patients with Fabry disease	17
#3389 Ultrasound evaluation of fluid overload in hemodialysis patients: comparison between VExUS score and lung ultrasound in a cross-sectional study	17
#3716 Change in mGFR following bariatric surgery: A case-crossover study	17
#1085 Acute kidney injury in Iraqi cancer patients treated with immune checkpoint inhibitors. (project ICI-AKI Iraq) interim analysis	16
#3692 Granulomatous interstitial nephritis and immunodeficiency—a link to remember	16
#3225 Integrating telemedicine into peritoneal dialysis: a holistic model for palliative care in advanced CKD	16
#1936 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)	16
#1048 Why are felids at such a high risk of chronic kidney disease?	16
#1715 Online prediction of dialysis adequacy failure in hemodialysis	16
#2782 Clinician usage and perception of an AI-based model predicting peritoneal dialysis dropouts	16
Cognitive deficits associate with cerebral hypoxia during hemodialysis	16
FC006: Sex Differences in the Recognition, Monitoring and Management of Chronic Kidney Disease in Health Care	16
On the fragility of outcome measures of two individual patient data analyses from randomized controlled trials on online haemodiafiltration	16
#1795 Next-generation sequencing in chronic kidney disease of unknown etiology: a step toward precision medicine	16
#3838 Hungry bone syndrome (HBS) as an outcome of parathyroidectomy as a treatment of hyperparathyroidism in a third level hospital in a medium-income country	16
#3368 The implementation of a multi-faceted cardio-renal service on heart failure and renal outcomes: a retrospective cohort study	16
#2396 The potential of human-derived macrophages to study autosomal dominant polycystic kidney disease (ADPKD)	16
MO380: Bio-Conductivity Measurement for Electrical Impedance Tomography (EIT) in Chronic Kidney Disease—A Non-Invasive and Portable Monitoring Approach	16
Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury	15
FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients	15
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity	15
Global, regional and national burden of CKD in children and adolescents	15
Peer-reviewing and medical publication	15
Are patients with primary glomerular disease at increased risk of malignancy?	15
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease	15
#2984 SLE associated fibrillary glomerulonephritis vs SLE nephritis with fibrils: can a straightforward distinction always be made?	15
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines	15
Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies	15
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport	15
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis	15
Transition of care of adolescent kidney transplant recipients—a call to action	15
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease	15
Hippocampal subfield morphology in regular hemodialysis patients	15
FHL2 in arterial medial calcification in chronic kidney disease	15
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease	15
Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria	14
Time trends in preemptive kidney transplantation in Europe: an ERA registry study	14
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions: a randomized controlled trial	14
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy	14
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI	14
#560 The representation of multimorbidity and frailty in the development and validation of kidney failure risk prediction models – a systematic review	14
#2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE	14
Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study	14
CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future	14
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN	14
Clinical applications of artificial intelligence in autosomal dominant polycystic kidney disease	14
Towards carbon footprint measurement of the ERA Congress: five key strategies for greener events	14
Modeling Podocytopathies with Kidney Organoids	14
Uromodulin biology	13
MO589: Exertion2 Trial: THE Weight Gain Prevention in Renal Transplant Online Study—a Randomized Controlled Feasibility Trial	13
FC007: The Impact of Sex on the Risk Of Major Adverse Cardiovascular Events in Older Adults with Advanced Chronic Kidney Disease: Results from the Equal Study	13
MO402: Symmetric Dimethylarginine Inhibits Renal Fibrosis in Obstructive Kidneys	13
#3459 GLUCOSE-LOWERING THERAPIES IN END STAGE RENAL DISEASE: HOW CAN WE PREDICT THE RISK OF HYPOGLYCAEMIA?	13
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications	13
#4735 USEFULNESS OF CYSTATIN C IN MEASURING RENAL FUNCTION AND PREDICTING METHOTREXATE ASSOCIATED TOXICITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS	13
#5093 DIALYSIS PATIENTS AND BNT162B2MRNA VACCINE TYPE ARE RISK FACTORS FOR IMMUNITY FADING 9 MONTHS AFTER SARS-COV-2MRNA VACCINATION (DIA-VACC STUDY)	13
#5341 EFFECTS OF URIC ACID-LOWERING THERAPY ON RENAL OUTCOMES IN CKD PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS	13
#4494 DRUG UTILIZATION FOLLOWING INCIDENT CHRONIC KIDNEY DISEASE: AN OBSERVATIONAL STUDY IN THE UNITED STATES AND JAPAN	13
#4878 STUDYING THE EFFECTIVENESS OF PRASUGREL AND CLOPIDOGEL IN PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA WITH STAGE 2 CKD	13
Pediatric kidney care experience after the 2023 Türkiye earthquake	13
#2067 Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning techniques	13
MO019: Preclinical Efficacy of Direct AMPK Activation with a Novel Small Molecule–PXL770–For the Treatment of Autosomal Dominant Polycystic Kidney Disease	13
#4344 CHANGES IN ENERGY METABOLISM IN THE KIDNEY WITH TUBULOINTERSTITIAL FIBROSIS: AN EX VIVO WHOLE TISSUE 2D-COSY APPROACH	13
MO191: Humoral Immune Response of the Additional Chadox1 NCOV-19 Vaccine Following a Two-Dose Inactivated Whole-Virus SARS-COV-2 Vaccination in Patients on Dialysis	13
Long-term outcome of kidney function in patients with ANCA-associated vasculitis	13
MO430: Octogenarians Referred to the Nephrologist: Evolution and Progression Risk Factors	12
#5703 COVID-19, RENAL DAMAGE AND ITS EVOLUTION IN HOSPITALISED PATIENTS IN THE FIRST WAVE OF THE PANDEMIC: EXPERIENCE OF ONE CENTRE	12
MO669: Predictive Parameters of Automated PD Cycler Software for Diagnosis of Catheter Dysfunction	12